You are here: vision-research.eu » People » Research Groups » United Kingdom » Coupland, Sarah

Liverpool Ocular Oncology Research Group (LOORG)

The Liverpool Ocular Oncology Research Group’s (LOORG’s) mission is to conduct high quality basic, translational and clinical research into the pathogenesis and treatment of adult ocular tumours that will improve patient care and survival. The Liverpool Ocular Oncology Research Group (LOORG) was established by Professor Sarah Coupland and Professor Bertil Damato in 2006. Prof. Coupland has since lead the basic science and translational research portfolio, in addition to being a Consultant Pathologist at the Royal Liverpool University Hospital.

A major strength of the LOORG is the close collaboration between ocular oncology clinicians (Lead, Professor Heimann), pathologists and basic scientists (Dr Sarah Lake and Dr Helen Kalirai) which ensures that the research we conduct addresses the key questions that will bring about improved survival and quality of life for ocular oncology patients.

Group Leader

Sarah E. Coupland
[more information]

Contact

University of Liverpool

Molecular and Clinical Cancer Medicine
Institute of Translational Medicine
6th Floor, Duncan Building
L69 3GA Liverpool
United Kingdom

Phone: +44(0)151 706 4494
Fax: +44(0)151 706 5826

E-mail:
s.e.coupland[at]liverpool.ac.uk

Website:
www.loorg.org

Current Research Projects

  • Project 1:
    Identification of regulators of metastasis in uveal melanoma
  • Project 2:
    Proteomic discovery of serum biomarkers in metastatic uveal melanoma
  • Project 3:
    Estimating survival prognosis after treatment of choroidal melanoma
  • Project 4:
    Gross chromosomal abnormalities in iris melanoma
  • Project 5:
    Molecular characteristics of metastatic liver lesions in uveal melanoma: the search for therapeutic targets

Research Groups

People

Related Research Groups

clinical laboratory testing
Oops, an error occurred! Code: 2019021503033818b57cb4
conjunctiva
Oops, an error occurred! Code: 2019021503033885e1dc2c
disease gene mapping
Oops, an error occurred! Code: 2019021503033820f66cca
gene/expression
Oops, an error occurred! Code: 2019021503033891a16151
gene microarray
Oops, an error occurred! Code: 201902150303387b5e8117
genetics
Oops, an error occurred! Code: 20190215030338a41392b3
immunohistochemistry
Oops, an error occurred! Code: 201902150303381d01daa7
iris
Oops, an error occurred! Code: 201902150303388b68b3b2
melanoma
Oops, an error occurred! Code: 20190215030338a1df7d7d
oncology
Oops, an error occurred! Code: 20190215030338602a9c17
pathology: experimental
Oops, an error occurred! Code: 201902150303380fd3d021
pathology: human
Oops, an error occurred! Code: 201902150303389c646e8f
pathology techniques
Oops, an error occurred! Code: 20190215030338fe6f5dbf
tumors
Oops, an error occurred! Code: 20190215030338c344e9ee
uvea
Oops, an error occurred! Code: 20190215030338a736259e
vision and action
Oops, an error occurred! Code: 2019021503033842d05ffc
visual acuity
Oops, an error occurred! Code: 20190215030338ba62cbf2
uveal melanoma
Oops, an error occurred! Code: 201902150303381703b49e
conjunctival melanoma
Oops, an error occurred! Code: 20190215030338810ea8a7
intraocular and ocular adnexal lymphomas
Oops, an error occurred! Code: 201902150303382b679f29
pathology
Oops, an error occurred! Code: 20190215030338193c442c
translational studies
Oops, an error occurred! Code: 20190215030338379192f3